Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2021
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L01EF04
|
| gptkbp:genericName |
gptkb:trilaciclib
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cosela
|
| gptkbp:indication |
chemotherapy-induced myelosuppression
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:G1_Therapeutics
|
| gptkbp:mechanismOfAction |
CDK4/6 inhibitor
|
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
fatigue
headache hypokalemia injection site reactions hypophosphatemia hypocalcemia |
| gptkbp:usedFor |
small cell lung cancer chemotherapy
|
| gptkbp:bfsParent |
gptkb:trilaciclib
|
| gptkbp:bfsLayer |
8
|